Axsome Therapeutics Inc (AXSM)

23.69
-0.01(-0.06%)
  • Volume:
    747,677
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    21.85 - 23.98

AXSM Overview

Prev. Close
23.7
Day's Range
21.85-23.98
Revenue
-
Open
23.37
52 wk Range
19.38-78
EPS
-3.35
Volume
747,677
Market Cap
891.03M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
596,366
P/E Ratio
-
Beta
2.35
1-Year Change
-68.25%
Shares Outstanding
37,691,733
Next Earnings Date
Mar 17, 2022
What is your sentiment on Axsome Therapeutics Inc?
or
Vote to see community's results!

Axsome Therapeutics Inc Company Profile

Employees
106

Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders. The Company's core CNS portfolio includes five product candidates, which includes AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is an oral N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity for the treatment of major depressive disorder (MDD). AXS-07 is an oral multi-mechanistic medicine for the acute treatment of migraine. AXS-07 consists of MoSEIC (Molecular Solubility Enhanced Inclusion Complex) meloxicam and rizatriptan. AXS-09 is an oral NMDA receptor antagonist with multimodal activity consisting of esbupropion and dextromethorphan for the treatment of CNS disorders. AXS-12, reboxetine, is an oral medicine in development for the treatment of narcolepsy. AXS-14, esreboxetine is an oral medicine in development for the treatment of fibromyalgia.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellSell
Technical IndicatorsBuyStrong BuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • FDA positive news?
    0
    • What
      0
      • Slowly
        0
        • Time to buy today
          1
          • Will bounce 20% tomorrow
            3
            • 27.9 9/aug
              0
              • any comments for 2021?
                7
                • Holy cow! It was a rehearsal? Just smile and wait guys.
                  0
                  • Defintely time to buy not sell. Company is wxecpted to start brining in revenue this year so stock price will began to grow rapidly. Selling now is a BIG mistake
                    2
                    • Buy this even at 90$ A huge massive winner for 2020
                      2
                      • whay is massive winner?*
                        1
                    • I don't understand why to buy it on 100 when the company offers on 87
                      0
                      • So what are you saying Goin? It's just a bubble?
                        0
                      • Market cap is still less than half that of say AMRN and SAGE; and AXSM has equal or broader pipeline. I don't see this collapsing any time soon, even if migraine trial disappoints (depression drug combo alone could carry this valuation).
                        0
                      • shay levi . No just fun to watch. I'm not a bull or bear.
                        0
                    • Announces public offering after close; goes UP 5% in AH trade. o_O Looks like $100 will come before the migraine trial results
                      0
                      • Now I sell the falling knife
                        0
                        • Might regret it, results for the migraine trial coming soon. Nothing wrong with securing profit though!
                          0
                        • I got in at 14, no regrets. Probably will keep a 3rd
                          0
                        • Check out Wavelife sciences, it just dropped today, but I've sold and resold it 3 times now on each drop with 30 to 50 percent gains
                          0
                      • Whoooooa, up 66% premarket! 100$ looking possible before EOY
                        0
                        • Up to 83% now... what a juggernaut. Crazy to think it was a 2 dollar stock less than a year ago.
                          0
                      • Great time to buy
                        0
                        • falling knife, selling shares to survive? any real investor knows any investment in pharmaceuticals would base on its pipeline, go educate yourself before you give your 2 cents which ain't worth a pack of chicklets from the homeless kid, who shares the same inversion narrative you baby investors. Good luck with that made up philosophy. While you're at it, riddle me this. Can you shoot me any other stock that went from a penny stock to a high of 30, with the lowest being in the high 18's at the lowest foundation support, which got back all its loss before the 2nd week? This stock will be worth triple digits by the end of 2020, thats with just one positive readout.
                          0
                          • If you haven't already bought it. Buy now even at 24. Strong pipeline for end of year. Plus all the insider buys and institutions should tell you something. I will sell at 36 having had bought at 12.31
                            3
                            • no revenue no fda and selling shares to survive... jumped from 3 to 30 in 6 months .... will see 7-8$ within next 30 days or so
                              1
                            • 0
                            • What did you say?
                              0
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.